Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Include preview-only content
  1. Article

    Open Access

    Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury

    The transcription factor NRF2, governed by its repressor KEAP1, protects cells against oxidative stress. There is interest in modelling the NRF2 response to improve the prediction of clinical toxicities such a...

    Ian M. Copple, Wouter den Hollander, Giulia Callegaro in Archives of Toxicology (2019)

  2. Article

    Open Access

    NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosis

    Expression of the glutamine transporter SNAT3 increases in kidney during metabolic acidosis, suggesting a role during ammoniagenesis. Microarray analysis of Nrf2 knock-out (KO) mouse kidney identified Snat3 as th...

    Adam Lister, Soline Bourgeois, Pedro H. Imenez Silva in Scientific Reports (2018)

  3. Article

    Open Access

    Real-time in vivo imaging reveals localised Nrf2 stress responses associated with direct and metabolism-dependent drug toxicity

    The transcription factor Nrf2 coordinates an adaptive response to chemical and oxidative stress characterised by the upregulated expression of cytoprotective target genes. In order to understand the mechanisti...

    Shiva S. Forootan, Fiona E. Mutter, Anja Kipar, Takao Iwawaki in Scientific Reports (2017)

  4. Article

    Open Access

    A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance

    K13 gene mutations are a primary marker of artemisinin resistance in Plasmodium falciparum malaria that threatens the long-term clinical utility of artemisinin-based combination therapies, the cornerstone of mode...

    Paul M. O’Neill, Richard K. Amewu, Susan A. Charman, Sunil Sabbani in Nature Communications (2017)

  5. Article

    Open Access

    Examination of the Cytotoxic and Embryotoxic Potential and Underlying Mechanisms of Next-Generation Synthetic Trioxolane and Tetraoxane Antimalarials

    Semisynthetic artemisinin-based therapies are the first-line treatment for P. falciparum malaria, but next-generation synthetic drug candidates are urgently required to improve availability and respond to the eme...

    Ian M. Copple, Amy E. Mercer, James Firman, Gail Donegan in Molecular Medicine (2012)

  6. Article

    Open Access

    Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy

    Nrf2 is a key transcriptional regulator of a battery of genes that facilitate phase II/III drug metabolism and defence against oxidative stress. Nrf2 is largely regulated by Keap1, which directs Nrf2 for prote...

    Adam Lister, Taoufik Nedjadi, Neil R Kitteringham, Fiona Campbell in Molecular Cancer (2011)